Mark Kaye - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & CFO
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 16:57:29 UTC
Previous filing
26 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kaye Mark EVP & CFO 220 VIRGINIA AVENUE, INDIANAPOLIS /s/ Kathleen S. Kiefer, Attorney in fact 04 Mar 2026 0001748691

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -271 -1.7% $294.07* 15,811 02 Mar 2026 Direct F1
transaction ELV Common Stock Award +6,377 +40% $0.000000* 22,188 02 Mar 2026 Direct F2
transaction ELV Common Stock Award +10,202 +46% $0.000000* 32,390 02 Mar 2026 Direct F3
transaction ELV Common Stock Tax liability -353 -1.1% $284.03* 32,037 03 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award +25,188 $0.000000* 25,188 02 Mar 2026 Common Stock 25,188 $294.07 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029.
F3 Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028.
F4 The option represents a right to purchase a total of 25,188 shares, and is exercisable in three annual installments, each installment of 8,396 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.